GLP-1 coverage is growing fast, but Sequoias data shows 85% of the employers who cover it have at least one restriction
Read the full FAQ here: #MunichReLifeNA #GLP1 #semagultide To view or add a comment, sign in When GLP-1 drugs like Ozempic and Wegovy moved from clinics to social media feeds, they became shorthand for weight loss sometimes framed as lifestyle choices rather than powerful, lifelong medications
An oral option for obesity could expand the addressable population
the prescription routes to a licensed compounding pharmacy (or, for branded products, a retail pharmacy)
It draws on publicly available patent data, FDA regulatory records, court decisions, financial filings, and the kind of competitive intelligence that services like DrugPatentWatch compile to help professionals track exactly where and when the next cliff is coming
Want to improve your long-term health